SOUTHWEST ONCOLOGY GROUP

西南肿瘤集团

• 批准号: 3556195
• 负责人: THOMAS Patrick MILLER
• 金额: $ 22.81万
• 依托单位: UNIVERSITY OF ARIZONA
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-01-01 至 1987-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3556195
• 关键词: Hodgkin's disease; adult human (21+); bleomycin; breast neoplasms; carmustine; combination cancer therapy; cooperative study; cyclophosphamide; doxorubicin; drug metabolism; fluorouracil; gastrointestinal neoplasms; head /neck neoplasm; human subject; human therapy evaluation; leukemia; lung neoplasms; lymphoma; melphalan; metastasis; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer radionuclide diagnosis; ovary neoplasms; pediatric neoplasm /cancer; prednisone; radiotracer; sarcoma; testis neoplasms; vincristine

We plan to continue our investigations of multimodality treatment of cancer in man through the Southwest Oncology Group (SWOG). Investigators from Arizona currently coordinate 26 clinical trials (17 phase II and 9 phase III). Investigators from Arizona serve as chairmen of three scientific disease committees (Lymphoma, Myeloma and Gynecologic Oncology. Arizona investigators are providing major scientific expertise and improved treatment results in several tumor types (myeloma, lymphoma, lung cancer, gynecologic cancer, melanoma) as well as in the areas of anticancer agent pharmacology, tumor cloning and hematopathology. We registered 184 patients on studies in 1982. Investigators from Arizona have published 74 manuscripts relative to SWOG research. Funds are needed to support the disciplines of medical oncology, radiation oncology, surgery, pathology, and a stem cell laboratory for SWOG.

我们计划继续开展癌症综合治疗的研究